1. Leiferman KM. Eosinophils in atopic dermatitis. J Allergy Clin Immunol. 1994; 94:1310–1317. PMID:
7798571.
2. Leiferman KM. A current perspective on the role of eosinophils in dermatologic diseases. J Am Acad Dermatol. 1991; 24:1101–1112. PMID:
2071704.
3. Ott NL, Gleich GJ, Peterson EA, Fujisawa T, Sur S, Leiferman KM. Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late-phase reaction. J Allergy Clin Immunol. 1994; 94:120–128. PMID:
8027490.
4. Peters MS, Schroeter AL, Kephart GM, Gleich GJ. Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol. 1983; 81:39–43. PMID:
6345685.
5. Walker C, Kägi MK, Ingold P, Braun P, Blaser K, Bruijnzeel-Koomen CA, et al. Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity. Clin Exp Allergy. 1993; 23:145–153. PMID:
8448682.
6. Czech W, Krutmann J, Schöpf E, Kapp A. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol. 1992; 126:351–355. PMID:
1571256.
7. Kägi MK, Joller-Jemelka H, Wüthrich B. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology. 1992; 185:88–92. PMID:
1421636.
8. Walsh GM. Eosinophil granule proteins and their role in disease. Curr Opin Hematol. 2001; 8:28–33. PMID:
11138623.
9. Hoffman DR, Yamamoto FY, Geller B, Haddad Z. Specific IgE antibodies in atopic eczema. J Allergy Clin Immunol. 1975; 55:256–267.
10. Sampson HA, Albergo R. Comparison of results of skin tests, RAST, and double-blind, placebo-controlled food challenges in children with atopic dermatitis. J Allergy Clin Immunol. 1984; 74:26–33. PMID:
6547461.
11. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today. 1990; 11:458–464. PMID:
2073318.
12. Coyle AJ, Wagner K, Bertrand C, Tsuyuki S, Bews J, Heusser C. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J Exp Med. 1996; 183:1303–1310. PMID:
8666888.
13. Rudikoff D, Lebwohl M. Atopic dermatitis. Lancet. 1998; 351:1715–1721. PMID:
9734903.
14. Park HJ, Kim EJ, Yoon D, Lee JK, Chang WS, Lim YM, et al. Prevalence of self-reported allergic diseases and IgE levels: a 2010 KNHANES analysis. Allergy Asthma Immunol Res. 2017; 9:329–339. PMID:
28497920.
15. Mehlhop PD, van de Rijn M, Goldberg AB, Brewer JP, Kurup VP, Martin TR, et al. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci U S A. 1997; 94:1344–1349. PMID:
9037055.
16. Hamelmann E, Takeda K, Schwarze J, Vella AT, Irvin CG, Gelfand EW. Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytes. Am J Respir Cell Mol Biol. 1999; 21:480–489. PMID:
10502558.
17. Ogawa K, Kaminuma O, Kikkawa H, Kameda R, Ikezawa K, Suko M, et al. Primary role of CD4+ T cells and supplemental role of mast cells in allergic pulmonary eosinophilia. Int Arch Allergy Immunol. 1999; 120(Suppl 1):15–18. PMID:
10529596.
18. Nishimura T, Saeki M, Kaminuma O, Matsuoka K, Yonekawa H, Mori A, et al. Existence of antigen-specific immunoglobulin E is not sufficient for allergic nasal eosinophil infiltration in mice. Int Arch Allergy Immunol. 2013; 161(Suppl 2):125–128. PMID:
23711863.
19. Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today. 1992; 13:501–507. PMID:
1361126.
20. Kay AB. “Helper” (CD4+) T cells and eosinophils in allergy and asthma. Am Rev Respir Dis. 1992; 145:S22–S26. PMID:
1346489.
21. Lever R, Turbitt M, Sanderson A, MacKie R. Immunophenotyping of the cutaneous infiltrate and of the mononuclear cells in the peripheral blood in patients with atopic dermatitis. J Invest Dermatol. 1987; 89:4–7. PMID:
3298446.
22. Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol Today. 1991; 12:256–257. PMID:
1680337.
23. Kouro T, Takatsu K. IL-5- and eosinophil-mediated inflammation: from discovery to therapy. Int Immunol. 2009; 21:1303–1309. PMID:
19819937.
24. Murphy KM, Heimberger AB, Loh DY. Induction by antigen of intrathymic apoptosis of CD4
+CD8
+TCR
lo thymocytes
in vivo. Science. 1990; 250:1720–1723. PMID:
2125367.
25. Watanabe N, Kaminuma O, Kitamura N, Hiroi T. Induced Treg cells augment the Th17-mediated intestinal inflammatory response in a CTLA4-dependent manner. PLoS One. 2016; 11:e0150244. PMID:
26950218.
26. Kaminuma O, Ohtomo T, Mori A, Nagakubo D, Hieshima K, Ohmachi Y, et al. Selective down-regulation of Th2 cell-mediated airway inflammation in mice by pharmacological intervention of CCR4. Clin Exp Allergy. 2012; 42:315–325. PMID:
22092376.
27. Kaminuma O, Fujimura H, Fushimi K, Nakata A, Sakai A, Chishima S, et al. Dynamics of antigen-specific helper T cells at the initiation of airway eosinophilic inflammation. Eur J Immunol. 2001; 31:2669–2679. PMID:
11536165.
28. Pettipher ER, Salter ED, Showell HJ. Effect of
in vivo desensitization to leukotriene B4 on eosinophil infiltration in response to C5a in guinea-pig skin. Br J Pharmacol. 1994; 113:117–120. PMID:
7812600.
29. Kaminuma O, Mori A, Ogawa K, Nakata A, Kikkawa H, Naito K, et al. Successful transfer of late phase eosinophil infiltration in the lung by infusion of helper T cell clones. Am J Respir Cell Mol Biol. 1997; 16:448–454. PMID:
9115756.
30. Nishimura T, Kaminuma O, Saeki M, Kitamura N, Matsuoka K, Yonekawa H, et al. Essential contribution of CD4+ T cells to antigen-induced nasal hyperresponsiveness in experimental allergic rhinitis. PLoS One. 2016; 11:e0146686. PMID:
26752722.
31. Ponath PD, Qin S, Post TW, Wang J, Wu L, Gerard NP, et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med. 1996; 183:2437–2448. PMID:
8676064.
32. Daugherty BL, Siciliano SJ, DeMartino JA, Malkowitz L, Sirotina A, Springer MS. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med. 1996; 183:2349–2354. PMID:
8642344.
33. Velazquez JR, Teran LM. Chemokines and their receptors in the allergic airway inflammatory process. Clin Rev Allergy Immunol. 2011; 41:76–88. PMID:
20352527.
34. Warringa RA, Schweizer RC, Maikoe T, Kuijper PH, Bruijnzeel PL, Koendermann L. Modulation of eosinophil chemotaxis by interleukin-5. Am J Respir Cell Mol Biol. 1992; 7:631–636. PMID:
1449809.
35. Sehmi R, Wardlaw AJ, Cromwell O, Kurihara K, Waltmann P, Kay AB. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood. 1992; 79:2952–2959. PMID:
1316789.
36. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation
in vivo. J Exp Med. 1995; 182:1169–1174. PMID:
7561691.
37. Kita H, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ. Effect of steroids on immunoglobulin-induced eosinophil degranulation. J Allergy Clin Immunol. 1991; 87:70–77. PMID:
1991924.
38. Hossain M, Okubo Y, Sekiguchi M. Effects of various drugs (staurosporine, herbimycin A, ketotifen, theophylline, FK506 and cyclosporin A) on eosinophil viability. Arerugi. 1994; 43:711–717. PMID:
7520689.
39. Mori A, Suko M, Nishizaki Y, Kaminuma O, Kobayashi S, Matsuzaki G, et al. IL-5 production by CD4
+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int Immunol. 1995; 7:449–457. PMID:
7540862.